{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T17:25:54Z","timestamp":1795281954421,"version":"4.10.3"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Antiplatelet agents are typically withheld perioperatively because of bleeding concerns. Dual antiplatelet therapy, such as aspirin and clopidogrel, has significant morbidity and mortality benefits in patients with ischemic heart disease or peripheral vascular disease. This study aims to evaluate the impact of perioperative dual antiplatelet therapy in the lower extremity free tissue transfer population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Lower extremity free tissue transfers performed by the senior author (K.K.E.) from 2011 to 2019 were retrospectively reviewed. Demographics, comorbidities, perioperative dual antiplatelet therapy, and free tissue transfer characteristics were recorded. Outcomes of interest included flap success, hematoma formation, blood transfusion requirements, and cardiac event occurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred ninety-five free tissue transfers were included. Median age at the time of free tissue transfer was 56.5 years. Median Charlson Comorbidity Index was 3. Thirty-four patients were on clopidogrel, which was either withheld (<jats:italic toggle=\"yes\">n<\/jats:italic> = 20) or continued (<jats:italic toggle=\"yes\">n<\/jats:italic> = 14) on the day of free tissue transfer. Incidence of blood transfusion was significantly higher in both the withheld and continued versus nonclopidogrel groups. Flap success was statistically equivalent between groups (withheld, 90.0 percent; continued, 92.9 percent; nonclopidogrel, 95.0 percent; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.346). Cardiac events occurred most often in the continued group (21.4 percent) compared to the withheld (5.0 percent) and nonclopidogrel (0.6 percent) groups. On multivariate analysis, holding clopidogrel remained significant for increased odds of postoperative transfusion. The clopidogrel group was no longer significant for intraoperative transfusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Despite increases in volume of blood products transfused, free tissue transfer can be performed safely with perioperative dual antiplatelet therapy. Withholding dual antiplatelet therapy on the day of free tissue transfer was not associated with decreased intraoperative transfusion; thus, dual antiplatelet therapy can safely be continued throughout the operative course to minimize cardiovascular risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000008666","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T20:04:59Z","timestamp":1640203499000},"page":"95e-103e","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Should Antiplatelet Therapy Be Withheld Perioperatively? The First Study Examining Outcomes in Patients Receiving Dual Antiplatelet Therapy in the Lower Extremity Free Flap Population"],"prefix":"10.1097","volume":"149","author":[{"given":"Mark D.","family":"Mishu","sequence":"first","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Zolper","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige K.","family":"Dekker","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Fleury","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna C.","family":"Bekeny","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Fan","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Attinger","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Evans","sequence":"additional","affiliation":[{"name":"From the Georgetown University School of Medicine; and Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/0970-0358.118600","article-title":"Unfavourable results in free tissue transfer.","volume":"46","author":"Koul","year":"2013","journal-title":"Indian J Plast Surg"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0036-1571359","article-title":"Successful salvage of late anastomotic thrombosis after free tissue transfer.","volume":"32","author":"Henderson","year":"2016","journal-title":"J Reconstr Microsurg"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bjps.2011.12.014","article-title":"Why haematomas cause flap failure: An evidence-based paradigm.","volume":"65","author":"Glass","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"370","DOI":"10.21053\/ceo.2015.01781","article-title":"Testing a new anticoagulation method for free flap reconstruction of head and neck cancers.","volume":"9","author":"Karimi","year":"2016","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/01.MLG.0000163539.97485.F4","article-title":"Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps.","volume":"115","author":"Chien","year":"2005","journal-title":"Laryngoscope"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/01.PRS.0000083378.58757.54","article-title":"Dextran-related complications in head and neck microsurgery: Do the benefits outweigh the risks? A prospective randomized analysis.","volume":"112","author":"Disa","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/micr.21958","article-title":"The outcome of prostaglandin-E1 and dextran-40 compared to no antithrombotic therapy in head and neck free tissue transfer: Analysis of 1,351 cases in a single center.","volume":"32","author":"Riva","year":"2012","journal-title":"Microsurgery"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00006534-199809010-00015","article-title":"A prospective study of microvascular free-flap surgery and outcome.","volume":"102","author":"Khouri","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"35833","DOI":"10.1038\/srep35833","article-title":"Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.","volume":"6","author":"Fichter","year":"2016","journal-title":"Sci Rep"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.prs.0000279327.75083.ae","article-title":"Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb\/IIIa inhibitor tirofiban.","volume":"120","author":"Chung","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000637-199508000-00009","article-title":"Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.","volume":"35","author":"Li","year":"1995","journal-title":"Ann Plast Surg"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0007-1226(94)90112-0","article-title":"The role of various antithrombotic agents in microvascular surgery.","volume":"47","author":"Buckley","year":"1994","journal-title":"Br J Plast Surg"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"49e","DOI":"10.1097\/01.prs.0000299267.84139.2a","article-title":"Is the use of intraoperative heparin safe?","volume":"121","author":"Chen","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"R14-20250502","first-page":"e56","article-title":"Heart disease and stroke statistics\u20132019 update: A report from the American Heart Association.","volume":"3139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13643-017-0635-z","article-title":"Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: A systematic review.","volume":"7","author":"Childers","year":"2018","journal-title":"Syst Rev"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.juro.2010.02.2391","article-title":"Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents.","volume":"183","author":"Eberli","year":"2010","journal-title":"J Urol"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"621","DOI":"10.21873\/invivo.11519","article-title":"Perioperative management of antiplatelet therapy in patients with history of coronary artery disease undergoing surgery for esophageal cancer: A single-center experience.","volume":"33","author":"Schizas","year":"2019","journal-title":"In Vivo"},{"key":"R18-20250502","first-page":"CD012584","article-title":"Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.","volume":"7","author":"Lewis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20250502","first-page":"473","article-title":"Aspirin before elective surgery: Stop or continue?","volume":"114","author":"Pl\u00fcmer","year":"2017","journal-title":"Dtsch Aerzteblatt Online"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/CM9.0000000000000186","article-title":"Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery.","volume":"132","author":"Hu","year":"2019","journal-title":"Chin Med J (Engl.)"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis.","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1097\/01.prs.0000260598.24376.e1","article-title":"Free flap reexploration: Indications, treatment, and outcomes in 1193 free flaps.","volume":"119","author":"Bui","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2003-42630","article-title":"Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection.","volume":"19","author":"Nakatsuka","year":"2003","journal-title":"J Reconstr Microsurg"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0194599812463320","article-title":"Effect of postoperative aspirin on outcomes in microvascular free tissue transfer surgery.","volume":"148","author":"Lighthall","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10156-010-0108-y","article-title":"Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital.","volume":"16","author":"Karakida","year":"2010","journal-title":"J Infect Chemother"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/PRS.0000000000000839","article-title":"Emerging paradigms in perioperative management for microsurgical free tissue transfer: Review of the literature and evidence-based guidelines.","volume":"135","author":"Motakef","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1357275","article-title":"Intraoperative transfusion of packed red blood cells in microvascular free tissue transfer patients: Assessment of 30-day morbidity using the NSQIP dataset.","volume":"30","author":"Kim","year":"2014","journal-title":"J Reconstr Microsurg"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0038-1648244","article-title":"Effects of transfusion on free flap survival: Searching for an optimal hemoglobin threshold for transfusion.","volume":"34","author":"Kim","year":"2018","journal-title":"J Reconstr Microsurg"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/micr.22223","article-title":"Analysis of risk factors associated with microvascular free flap failure using a multi-institutional database.","volume":"35","author":"Wong","year":"2015","journal-title":"Microsurgery"},{"issue":"Suppl 1","key":"R30-20250502","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/SAP.0000000000002335","article-title":"Free anterolateral thigh versus vastus lateralis muscle flaps for coverage of lower extremity defects in chronic wounds.","volume":"85","author":"Black","year":"2020","journal-title":"Ann Plast Surg"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-2000-8395","article-title":"CoStasis provides superior control of diffuse bleeding at muscle-flap donor sites, compared to manual compression.","volume":"16","author":"Buncke","year":"2000","journal-title":"J Reconstr Microsurg"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"Suppl","key":"R33-20250502","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication.","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/1358863X17701592","article-title":"2016 AHA\/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive summary.","volume":"22","author":"Gerhard-Herman","year":"2017","journal-title":"Vasc Med"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s choice: 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.295.5.547","article-title":"Medical treatment of peripheral arterial disease.","volume":"295","author":"Hankey","year":"2006","journal-title":"JAMA"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:06:18Z","timestamp":1746151578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000008666","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}